MAP2K1 and leukemia: Then, to rule out the possibility that the oncoprotein protein BCR::ABL1 could act as a bridging adapter molecule for connecting MEK1/2 to ABL1 and/or BCR kinases, we performed parallel co-immunoprecipitation experiments using the BCR::ABL1-negative NB4 leukemia cells.